financetom
Business
financetom
/
Business
/
Ryman Hospitality Properties Insider Bought Shares Worth $809,864, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ryman Hospitality Properties Insider Bought Shares Worth $809,864, According to a Recent SEC Filing
Jun 9, 2025 2:13 PM

04:55 PM EDT, 06/09/2025 (MT Newswires) -- Colin V Reed, Director, Executive Chairman of the Board, on June 09, 2025, executed a purchase for 8,356 shares in Ryman Hospitality Properties ( RHP ) for $809,864. Following the Form 4 filing with the SEC, Reed has control over a total of 1,429,695 common shares of the company, with 870,406 shares held directly and 559,289 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1040829/000095017025083810/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: CoreWeave Offers $5.75 Per Share for Core Scientific
Market Chatter: CoreWeave Offers $5.75 Per Share for Core Scientific
Jun 4, 2024
08:48 AM EDT, 06/04/2024 (MT Newswires) -- CoreWeave has made an offer to acquire Core Scientific ( CORZ ) for $5.75 per share, Bloomberg reported Tuesday, citing a person with knowledge of the matter. The all-cash offer was made Monday and comes as CoreWeave seeks to enhance its artificial intelligence data center capacity, Bloomberg reported, citing the person. The offer...
Boeing's Calhoun says its board is ready to make decisions for succession
Boeing's Calhoun says its board is ready to make decisions for succession
Jun 4, 2024
BERLIN (Reuters) - Boeing's ( BA ) board is prepared to make decisions as the planemaker's Chief Executive David Calhoun is set to step down at the end of the year, he told Reuters on Wednesday, adding that the decision on his successor is up to the board. The board is prepared to make their decisions, they have time to...
BridgeBio Pharma Phase 2 Trial of Infigratinib Shows 'Continued Well-Tolerated Safety Profile'; Starts Phase 3 Trial Enrollment
BridgeBio Pharma Phase 2 Trial of Infigratinib Shows 'Continued Well-Tolerated Safety Profile'; Starts Phase 3 Trial Enrollment
Jun 4, 2024
08:45 AM EDT, 06/04/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said late Monday its group 5 dose escalation in a phase 2 trial of infigratinib, an investigational therapy to treat children with achondroplasia, a growth deficiency, is showing a continued well-tolerated safety profile. The trial, Propel 2, demonstrated a mean increase in annualized height velocity, with a +2.51...
Sector Update: Consumer
Sector Update: Consumer
Jun 4, 2024
08:49 AM EDT, 06/04/2024 (MT Newswires) -- Consumer stocks were flat to lower premarket Tuesday, with the Consumer Staples Select Sector SPDR Fund (XLP) inactive and the Consumer Discretionary Select Sector SPDR Fund (XLY) recently down 0.4%. Bath & Body Works ( BBWI ) fell more than 6% after it reported fiscal Q1 net sales of $1.38 billion, down from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved